Polianta Ltd’s Seagen Inc. Common Stock SGEN Stock Holding History

Polianta Ltd’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,100	Closed	-$1.24M	–	103
2020 Q4	$1.24M	Buy	+7,100	New	+$1.32M	0.69%	35

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Polianta Ltd's SGEN Position: Q1 2021 in Review

Polianta Ltd sold out of Seagen Inc. Common Stock (SGEN) in Q1 2021, closing a stake of 7,100 shares — an estimated $1.24M sold.

Polianta Ltd first reported a position in SGEN in Q4 2020 and held it in 1 quarter. The position peaked at $1.24M in Q4 2020. 502 funds tracked by Wall St. Rank hold SGEN as of Q1 2021.

Polianta Ltd reported no remaining Seagen Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Polianta Ltd sold 7,100 Seagen Inc. Common Stock shares in Q1 2021, an estimated $1.24M.
Polianta Ltd first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Polianta Ltd's Seagen Inc. Common Stock position peaked at $1.24M in Q4 2020.
502 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2021.

Based on Polianta Ltd's 13F filing for Q1 2021, filed 14 Apr 2021.